Global Neurological Disorder Drugs Sales Market Report 2021

1 Neurological Disorder Drugs Market Overview

• 1.1 Neurological Disorder Drugs Product Scope
• 1.2 Neurological Disorder Drugs Segment by Type
  • 1.2.1 Global Neurological Disorder Drugs Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Antipsychotic
  • 1.2.3 Hypnotic & Sedative
  • 1.2.4 Analgesics
  • 1.2.5 Anticoagulants
  • 1.2.6 Others
• 1.3 Neurological Disorder Drugs Segment by Application
  • 1.3.1 Global Neurological Disorder Drugs Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
• 1.4 Neurological Disorder Drugs Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Neurological Disorder Drugs Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Neurological Disorder Drugs Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Neurological Disorder Drugs Price Trends (2016-2027)

2 Neurological Disorder Drugs Estimates and Forecasts by Region

• 2.1 Global Neurological Disorder Drugs Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Neurological Disorder Drugs Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Neurological Disorder Drugs Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Neurological Disorder Drugs Revenue Market Share by Region (2016-2021)
• 2.3 Global Neurological Disorder Drugs Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Neurological Disorder Drugs Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Neurological Disorder Drugs Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Neurological Disorder Drugs Estimates and Projections (2016-2027)
  • 2.4.2 Europe Neurological Disorder Drugs Estimates and Projections (2016-2027)
  • 2.4.3 China Neurological Disorder Drugs Estimates and Projections (2016-2027)
  • 2.4.4 Japan Neurological Disorder Drugs Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Neurological Disorder Drugs Estimates and Projections (2016-2027)
  • 2.4.6 India Neurological Disorder Drugs Estimates and Projections (2016-2027)

3 Global Neurological Disorder Drugs Competition Landscape by Players

• 3.1 Global Top Neurological Disorder Drugs Players by Sales (2016-2021)
• 3.2 Global Top Neurological Disorder Drugs Players by Revenue (2016-2021)
• 3.3 Global Neurological Disorder Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neurological Disorder Drugs as of 2020)
• 3.4 Global Neurological Disorder Drugs Average Price by Company (2016-2021)
• 3.5 Manufacturers Neurological Disorder Drugs Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Neurological Disorder Drugs Market Size by Type

• 4.1 Global Neurological Disorder Drugs Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Neurological Disorder Drugs Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Neurological Disorder Drugs Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Neurological Disorder Drugs Price by Type (2016-2021)
• 4.2 Global Neurological Disorder Drugs Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Neurological Disorder Drugs Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Neurological Disorder Drugs Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Neurological Disorder Drugs Price Forecast by Type (2022-2027)

5 Global Neurological Disorder Drugs Market Size by Application

• 5.1 Global Neurological Disorder Drugs Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Neurological Disorder Drugs Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Neurological Disorder Drugs Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Neurological Disorder Drugs Price by Application (2016-2021)
• 5.2 Global Neurological Disorder Drugs Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Neurological Disorder Drugs Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Neurological Disorder Drugs Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Neurological Disorder Drugs Price Forecast by Application (2022-2027)

6 North America Neurological Disorder Drugs Market Facts & Figures

• 6.1 North America Neurological Disorder Drugs Sales by Company
  • 6.1.1 North America Neurological Disorder Drugs Sales by Company (2016-2021)
  • 6.1.2 North America Neurological Disorder Drugs Revenue by Company (2016-2021)
• 6.2 North America Neurological Disorder Drugs Sales Breakdown by Type
  • 6.2.1 North America Neurological Disorder Drugs Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Neurological Disorder Drugs Sales Breakdown by Type (2022-2027)
• 6.3 North America Neurological Disorder Drugs Sales Breakdown by Application
  • 6.3.1 North America Neurological Disorder Drugs Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Neurological Disorder Drugs Sales Breakdown by Application (2022-2027)

7 Europe Neurological Disorder Drugs Market Facts & Figures

• 7.1 Europe Neurological Disorder Drugs Sales by Company
  • 7.1.1 Europe Neurological Disorder Drugs Sales by Company (2016-2021)
  • 7.1.2 Europe Neurological Disorder Drugs Revenue by Company (2016-2021)
• 7.2 Europe Neurological Disorder Drugs Sales Breakdown by Type
  • 7.2.1 Europe Neurological Disorder Drugs Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Neurological Disorder Drugs Sales Breakdown by Type (2022-2027)
• 7.3 Europe Neurological Disorder Drugs Sales Breakdown by Application
  • 7.3.1 Europe 115 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 115 Sales Breakdown by Application (2022-2027)

8 China Neurological Disorder Drugs Market Facts & Figures

• 8.1 China Neurological Disorder Drugs Sales by Company
  • 8.1.1 China Neurological Disorder Drugs Sales by Company (2016-2021)
  • 8.1.2 China Neurological Disorder Drugs Revenue by Company (2016-2021)
• 8.2 China Neurological Disorder Drugs Sales Breakdown by Type
  • 8.2.1 China Neurological Disorder Drugs Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Neurological Disorder Drugs Sales Breakdown by Type (2022-2027)
• 8.3 China Neurological Disorder Drugs Sales Breakdown by Application
  • 8.3.1 China 142 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 142 Sales Breakdown by Application (2022-2027)

9 Japan Neurological Disorder Drugs Market Facts & Figures

• 9.1 Japan Neurological Disorder Drugs Sales by Company
  • 9.1.1 Japan Neurological Disorder Drugs Sales by Company (2016-2021)
  • 9.1.2 Japan Neurological Disorder Drugs Revenue by Company (2016-2021)
• 9.2 Japan Neurological Disorder Drugs Sales Breakdown by Type
  • 9.2.1 Japan Neurological Disorder Drugs Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Neurological Disorder Drugs Sales Breakdown by Type (2022-2027)
• 9.3 Japan Neurological Disorder Drugs Sales Breakdown by Application
  • 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Neurological Disorder Drugs Market Facts & Figures

• 10.1 Southeast Asia Neurological Disorder Drugs Sales by Company
  • 10.1.1 Southeast Asia Neurological Disorder Drugs Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Neurological Disorder Drugs Revenue by Company (2016-2021)
• 10.2 Southeast Asia Neurological Disorder Drugs Sales Breakdown by Type
  • 10.2.1 Southeast Asia Neurological Disorder Drugs Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Neurological Disorder Drugs Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Neurological Disorder Drugs Sales Breakdown by Application
  • 10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)

11 India Neurological Disorder Drugs Market Facts & Figures

• 11.1 India Neurological Disorder Drugs Sales by Company
  • 11.1.1 India Neurological Disorder Drugs Sales by Company (2016-2021)
  • 11.1.2 India Neurological Disorder Drugs Revenue by Company (2016-2021)
• 11.2 India Neurological Disorder Drugs Sales Breakdown by Type
  • 11.2.1 India Neurological Disorder Drugs Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Neurological Disorder Drugs Sales Breakdown by Type (2022-2027)
• 11.3 India Neurological Disorder Drugs Sales Breakdown by Application
  • 11.3.1 India Neurological Disorder Drugs Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Neurological Disorder Drugs Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Neurological Disorder Drugs Business

• 12.1 Novartis
  • 12.1.1 Novartis Corporation Information
  • 12.1.2 Novartis Business Overview
  • 12.1.3 Novartis Neurological Disorder Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Novartis Neurological Disorder Drugs Products Offered
  • 12.1.5 Novartis Recent Development
• 12.2 GlaxoSmithKline
  • 12.2.1 GlaxoSmithKline Corporation Information
  • 12.2.2 GlaxoSmithKline Business Overview
  • 12.2.3 GlaxoSmithKline Neurological Disorder Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 GlaxoSmithKline Neurological Disorder Drugs Products Offered
  • 12.2.5 GlaxoSmithKline Recent Development
• 12.3 Merck & Co.
  • 12.3.1 Merck & Co. Corporation Information
  • 12.3.2 Merck & Co. Business Overview
  • 12.3.3 Merck & Co. Neurological Disorder Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Merck & Co. Neurological Disorder Drugs Products Offered
  • 12.3.5 Merck & Co. Recent Development
• 12.4 Bayer
  • 12.4.1 Bayer Corporation Information
  • 12.4.2 Bayer Business Overview
  • 12.4.3 Bayer Neurological Disorder Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Bayer Neurological Disorder Drugs Products Offered
  • 12.4.5 Bayer Recent Development
• 12.5 AstraZeneca
  • 12.5.1 AstraZeneca Corporation Information
  • 12.5.2 AstraZeneca Business Overview
  • 12.5.3 AstraZeneca Neurological Disorder Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 AstraZeneca Neurological Disorder Drugs Products Offered
  • 12.5.5 AstraZeneca Recent Development
• 12.6 Boehringer Ingelheim
  • 12.6.1 Boehringer Ingelheim Corporation Information
  • 12.6.2 Boehringer Ingelheim Business Overview
  • 12.6.3 Boehringer Ingelheim Neurological Disorder Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Boehringer Ingelheim Neurological Disorder Drugs Products Offered
  • 12.6.5 Boehringer Ingelheim Recent Development
• 12.7 Teva Pharmaceutical
  • 12.7.1 Teva Pharmaceutical Corporation Information
  • 12.7.2 Teva Pharmaceutical Business Overview
  • 12.7.3 Teva Pharmaceutical Neurological Disorder Drugs Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Teva Pharmaceutical Neurological Disorder Drugs Products Offered
  • 12.7.5 Teva Pharmaceutical Recent Development

...

13 Neurological Disorder Drugs Manufacturing Cost Analysis

• 13.1 Neurological Disorder Drugs Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Neurological Disorder Drugs
• 13.4 Neurological Disorder Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Neurological Disorder Drugs Distributors List
• 14.3 Neurological Disorder Drugs Customers

15 Market Dynamics

• 15.1 Neurological Disorder Drugs Market Trends
• 15.2 Neurological Disorder Drugs Drivers
• 15.3 Neurological Disorder Drugs Market Challenges
• 15.4 Neurological Disorder Drugs Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List